United States Biotechnology & Medical Research

Dicerna Pharmaceuticals Inc (DRNA)

Track

Stock chart
Ticker: DRNA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Brown Bob D
Chief Scientific Ofr., EVP R&D
1 sale — total 946,072 USD
Planned sale 18 Nov 2021
Value US$4,407,245.12 | Price 394.58 | Shares 86,893
Sale 17 Sep 2021
Value US$721,647.60 | Price 184.72 | Shares 41,111
Sale 17 Sep 2021
Value US$44,142.32 | Price 21.47 | Shares 2,056
Planned buy 10 Aug 2021
Value US$110,480.00 | Price 22.10 | Shares 5,000
Sale 22 Jun 2021
Value US$179,148.70 | Price 36.71 | Shares 4,880
Sale 22 Jun 2021
Value US$502,832.21 | Price 37.10 | Shares 13,555
Sale 17 Jun 2021
Value US$310,068.10 | Price 35.79 | Shares 8,664
Sale 16 Jun 2021
Value US$3,615.00 | Price 36.15 | Shares 100
Sale 16 Jun 2021
Value US$1,121,011.98 | Price 35.63 | Shares 31,464
Planned sale 14 Jun 2021
Value US$760,000.00 | Price 38.00 | Shares 20,000
Planned sale 11 Jun 2021
Value US$350,000.00 | Price 35.00 | Shares 10,000
Planned sale 7 Jun 2021
Value US$330,000.00 | Price 33.00 | Shares 10,000
Planned sale 1 Jun 2021
Value US$9,750.45 | Price 31.97 | Shares 305
Planned sale 1 Jun 2021
Value US$127,327.95 | Price 30.86 | Shares 4,126
Planned sale 3 May 2021
Value US$14,843.04 | Price 31.25 | Shares 475
Planned sale 3 May 2021
Value US$119,349.36 | Price 30.17 | Shares 3,956
Planned sale 3 May 2021
Value US$759.84 | Price 31.66 | Shares 24
Planned sale 3 May 2021
Value US$35,196.69 | Price 31.01 | Shares 1,135
Planned sale 3 May 2021
Value US$215,715.88 | Price 30.16 | Shares 7,153
Planned sale 16 Apr 2021
Value US$147,070.96 | Price 29.99 | Shares 4,904
Planned sale 1 Apr 2021
Value US$4,981.06 | Price 26.50 | Shares 188
Planned sale 1 Apr 2021
Value US$210,044.40 | Price 25.85 | Shares 8,124
Planned sale 1 Apr 2021
Value US$114,563.95 | Price 25.86 | Shares 4,431
Planned sale 1 Mar 2021
Value US$23,089.81 | Price 29.49 | Shares 783
Planned sale 1 Mar 2021
Value US$217,611.44 | Price 28.90 | Shares 7,529
Planned sale 1 Mar 2021
Value US$10,491.28 | Price 29.47 | Shares 356
Planned sale 1 Mar 2021
Value US$117,847.78 | Price 28.92 | Shares 4,075
Planned sale 5 Feb 2021
Value US$193,140.44 | Price 26.99 | Shares 7,156
Planned sale 3 Feb 2021
Value US$207,800.00 | Price 25.00 | Shares 8,312
Planned sale 2 Feb 2021
Value US$106,344.00 | Price 24.00 | Shares 4,431
Planned sale 25 Jan 2021
Value US$540,750.00 | Price 25.00 | Shares 21,630
Planned sale 25 Jan 2021
Value US$158,150.00 | Price 25.00 | Shares 6,326
Planned sale 12 Jan 2021
Value US$139,817.15 | Price 24.07 | Shares 5,808
Planned sale 12 Jan 2021
Value US$139,868.26 | Price 24.08 | Shares 5,808
Planned sale 11 Jan 2021
Value US$91,162.00 | Price 23.99 | Shares 3,800
Sale 10 Dec 2020
Value US$23,400,000.00 | Price 23.40 | Shares 1,000,000
Planned sale 1 Dec 2020
Value US$109,902.96 | Price 25.21 | Shares 4,360
Planned sale 1 Dec 2020
Value US$206,205.52 | Price 25.19 | Shares 8,185
Planned sale 4 Nov 2020
Value US$348,750.00 | Price 23.25 | Shares 15,000
Planned sale 4 Nov 2020
Value US$333,750.00 | Price 22.25 | Shares 15,000
Planned sale 2 Nov 2020
Value US$172,130.55 | Price 21.03 | Shares 8,185
Planned sale 2 Nov 2020
Value US$91,333.28 | Price 20.95 | Shares 4,360
Planned sale 16 Oct 2020
Value US$343,770.00 | Price 21.00 | Shares 16,370
Planned sale 15 Oct 2020
Value US$176,144.00 | Price 20.20 | Shares 8,720
Buy 1 Sep 2020
Value US$180,597.00 | Price 18.06 | Shares 10,000
Planned sale 3 Aug 2020
Value US$32,648.60 | Price 22.80 | Shares 1,432
Planned sale 3 Aug 2020
Value US$65,329.54 | Price 22.31 | Shares 2,928
Planned sale 3 Aug 2020
Value US$57,478.55 | Price 22.80 | Shares 2,521
Planned sale 3 Aug 2020
Value US$126,508.27 | Price 22.34 | Shares 5,664
Planned sale 1 Jul 2020
Value US$35,116.21 | Price 26.87 | Shares 1,307
Planned sale 1 Jul 2020
Value US$80,562.87 | Price 26.39 | Shares 3,053
Planned sale 1 Jul 2020
Value US$63,669.17 | Price 26.85 | Shares 2,371
Planned sale 1 Jul 2020
Value US$153,259.37 | Price 26.36 | Shares 5,814
Planned sale 19 Jun 2020
Value US$241,750.00 | Price 25.00 | Shares 9,670
Planned sale 1 Jun 2020
Value US$91,807.21 | Price 21.06 | Shares 4,360
Planned sale 1 Jun 2020
Value US$171,959.48 | Price 21.01 | Shares 8,185
Planned sale 11 May 2020
Value US$318,744.00 | Price 24.00 | Shares 13,281
Planned sale 5 May 2020
Value US$171,885.00 | Price 21.00 | Shares 8,185
Planned sale 4 May 2020
Value US$88,072.00 | Price 20.20 | Shares 4,360
Planned sale 20 Apr 2020
Value US$588,070.80 | Price 22.95 | Shares 25,624
Planned sale 20 Apr 2020
Value US$305,463.00 | Price 23.00 | Shares 13,281
Planned sale 17 Apr 2020
Value US$173,358.30 | Price 21.18 | Shares 8,185
Planned sale 13 Apr 2020
Value US$88,072.00 | Price 20.20 | Shares 4,360
Planned sale 7 Apr 2020
Value US$408,356.55 | Price 19.95 | Shares 20,469
Planned sale 2 Mar 2020
Value US$89,853.93 | Price 20.61 | Shares 4,360
Planned sale 2 Mar 2020
Value US$171,885.00 | Price 21.00 | Shares 8,185
Planned sale 10 Feb 2020
Value US$171,885.00 | Price 21.00 | Shares 8,185
Planned sale 3 Feb 2020
Value US$88,072.00 | Price 20.20 | Shares 4,360
Planned sale 17 Jan 2020
Value US$435,228.25 | Price 21.26 | Shares 20,469
Planned sale 17 Jan 2020
Value US$584,936.00 | Price 21.27 | Shares 27,500
Planned sale 2 Jan 2020
Value US$95,376.31 | Price 21.88 | Shares 4,360
Planned sale 31 Dec 2019
Value US$262,702.00 | Price 22.00 | Shares 11,941
Planned sale 30 Dec 2019
Value US$29,486.83 | Price 22.01 | Shares 1,340
Planned sale 30 Dec 2019
Value US$468,914.04 | Price 21.84 | Shares 21,466
Planned sale 26 Dec 2019
Value US$453,764.00 | Price 22.69 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-22 2021-11-18 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
86,893 -38.7%
394.58
US$4,407,245 		86,893 -38.7% 394.58 US$4,407,245
2021-09-17 2021-09-17 S Sale
Zeng Ling

Chief Legal Officer & Sec'y

Officer
41,111 -31.4%
184.72
US$721,648 		41,111 -31.4% 184.72 US$721,648
2021-09-17 2021-09-17 S Sale
Aradhye Shreeram

EVP & Chief Medical Officer

Officer
44,883 -6.9%
262.99
US$1,642,242 		44,883 -6.9% 262.99 US$1,642,242
2021-08-10 2021-08-10 PP Planned purchase
FAMBROUGH DOUGLAS

President and CEO

Executive Director
5,000 +13.1%
22.10
US$110,480 		5,000 +13.1% 22.10 US$110,480
2021-06-24 2021-06-22 S Sale
Paglia Regina M.

Chief Human Resources Officer

Officer
4,880 -94.8%
36.71
US$179,149 		4,880 -94.8% 36.71 US$179,149
2021-06-24 2021-06-22 S Sale
Paglia Regina M.

Chief Human Resources Officer

Officer
13,555 -72.5%
37.10
US$502,832 		13,555 -72.5% 37.10 US$502,832
2021-06-22 2021-06-17 S Sale
Paglia Regina M.

Chief Human Resources Officer

Officer
8,664 -97.0%
35.79
US$310,068 		8,664 -97.0% 35.79 US$310,068
2021-06-17 2021-06-16 S Sale
Paglia Regina M.

Chief Human Resources Officer

Officer
100 -27.1%
36.15
US$3,615 		100 -27.1% 36.15 US$3,615
2021-06-17 2021-06-16 S Sale
Paglia Regina M.

Chief Human Resources Officer

Officer
31,464 -98.8%
35.63
US$1,121,012 		31,464 -98.8% 35.63 US$1,121,012
2021-06-15 2021-06-14 PlS Planned sale
Ciappenelli Robert D.

Chief Commercial Officer

Officer
20,000 -84.1%
38.00
US$760,000 		20,000 -84.1% 38.00 US$760,000
2021-06-15 2021-06-11 PlS Planned sale
Ciappenelli Robert D.

Chief Commercial Officer

Officer
10,000 -72.6%
35.00
US$350,000 		10,000 -72.6% 35.00 US$350,000
2021-06-08 2021-06-07 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
10,000 -31.7%
33.00
US$330,000 		10,000 -31.7% 33.00 US$330,000
2021-06-03 2021-06-01 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
305 -100.0%
31.97
US$9,750 		305 -100.0% 31.97 US$9,750
2021-06-03 2021-06-01 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
4,126 -93.1%
30.86
US$127,328 		4,126 -93.1% 30.86 US$127,328
2021-05-05 2021-05-03 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
475 -100.0%
31.25
US$14,843 		475 -100.0% 31.25 US$14,843
2021-05-05 2021-05-03 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
3,956 -89.3%
30.17
US$119,349 		3,956 -89.3% 30.17 US$119,349
2021-05-05 2021-05-03 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
24 -0.1%
31.66
US$760 		24 -0.1% 31.66 US$760
2021-05-05 2021-05-03 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
1,135 -5.0%
31.01
US$35,197 		1,135 -5.0% 31.01 US$35,197
2021-05-05 2021-05-03 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
7,153 -24.0%
30.16
US$215,716 		7,153 -24.0% 30.16 US$215,716
2021-04-20 2021-04-16 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
4,904 -23.5%
29.99
US$147,071 		4,904 -23.5% 29.99 US$147,071
2021-04-05 2021-04-01 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
188 -0.9%
26.50
US$4,981 		188 -0.9% 26.50 US$4,981
2021-04-05 2021-04-01 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
8,124 -27.2%
25.85
US$210,044 		8,124 -27.2% 25.85 US$210,044
2021-04-05 2021-04-01 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
4,431 -100.0%
25.86
US$114,564 		4,431 -100.0% 25.86 US$114,564
2021-03-02 2021-03-01 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
783 -3.5%
29.49
US$23,090 		783 -3.5% 29.49 US$23,090
2021-03-02 2021-03-01 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
7,529 -25.2%
28.90
US$217,611 		7,529 -25.2% 28.90 US$217,611
2021-03-02 2021-03-01 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
356 -100.0%
29.47
US$10,491 		356 -100.0% 29.47 US$10,491
2021-03-02 2021-03-01 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
4,075 -92.0%
28.92
US$117,848 		4,075 -92.0% 28.92 US$117,848
2021-02-08 2021-02-05 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
7,156 -25.5%
26.99
US$193,140 		7,156 -25.5% 26.99 US$193,140
2021-02-04 2021-02-03 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
8,312 -27.9%
25.00
US$207,800 		8,312 -27.9% 25.00 US$207,800
2021-02-04 2021-02-02 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
4,431 -100.0%
24.00
US$106,344 		4,431 -100.0% 24.00 US$106,344
2021-01-27 2021-01-25 PlS Planned sale
Brown Bob D

Chief Scientific Ofr., EVP R&D

Officer
21,630 -50.1%
25.00
US$540,750 		21,630 -50.1% 25.00 US$540,750
2021-01-27 2021-01-25 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
6,326 -100.0%
25.00
US$158,150 		6,326 -100.0% 25.00 US$158,150
2021-01-13 2021-01-12 PlS Planned sale
Brown Bob D

See Remarks

Officer
5,808 -18.0%
24.07
US$139,817 		5,808 -18.0% 24.07 US$139,817
2021-01-13 2021-01-12 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
5,808 -17.1%
24.08
US$139,868 		5,808 -17.1% 24.08 US$139,868
2021-01-12 2021-01-11 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
3,800 -10.1%
23.99
US$91,162 		3,800 -10.1% 23.99 US$91,162
2020-12-14 2020-12-10 S Sale
4.0
Koppel Adam
Non-Executive Director
1,000,000 -24.5%
23.40
US$23,400,000 		1,000,000 -24.5% 23.40 US$23,400,000
2020-12-03 2020-12-01 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
4,360 -12.0%
25.21
US$109,903 		4,360 -12.0% 25.21 US$109,903
2020-12-03 2020-12-01 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -23.6%
25.19
US$206,206 		8,185 -23.6% 25.19 US$206,206
2020-11-06 2020-11-04 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
15,000 -100.0%
23.25
US$348,750 		15,000 -100.0% 23.25 US$348,750
2020-11-06 2020-11-04 PlS Planned sale
Paglia Regina M.

Chief Human Resources Officer

Officer
15,000 -50.0%
22.25
US$333,750 		15,000 -50.0% 22.25 US$333,750
2020-11-03 2020-11-02 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -23.6%
21.03
US$172,131 		8,185 -23.6% 21.03 US$172,131
2020-11-03 2020-11-02 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
4,360 -12.0%
20.95
US$91,333 		4,360 -12.0% 20.95 US$91,333
2020-10-20 2020-10-16 PlS Planned sale
Brown Bob D

See Remarks

Officer
16,370 -38.2%
21.00
US$343,770 		16,370 -38.2% 21.00 US$343,770
2020-10-19 2020-10-15 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
8,720 -28.5%
20.20
US$176,144 		8,720 -28.5% 20.20 US$176,144
2020-09-01 2020-09-01 B Purchase
FAMBROUGH DOUGLAS

President and CEO

Executive Director
10,000 +81.3%
18.06
US$180,597 		10,000 +81.3% 18.06 US$180,597
2020-08-05 2020-08-03 PlS Planned sale
Weissman James B

EVP & Chief Operating Officer

Officer
1,432 -6.1%
22.80
US$32,649 		1,432 -6.1% 22.80 US$32,649
2020-08-05 2020-08-03 PlS Planned sale
Weissman James B

EVP & Chief Operating Officer

Officer
2,928 -11.2%
22.31
US$65,330 		2,928 -11.2% 22.31 US$65,330
2020-08-05 2020-08-03 PlS Planned sale
Brown Bob D

See Remarks

Officer
2,521 -33.5%
22.80
US$57,479 		2,521 -33.5% 22.80 US$57,479
2020-08-05 2020-08-03 PlS Planned sale
Brown Bob D

See Remarks

Officer
5,664 -43.0%
22.34
US$126,508 		5,664 -43.0% 22.34 US$126,508
2020-07-06 2020-07-01 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
1,307 -5.6%
26.87
US$35,116 		1,307 -5.6% 26.87 US$35,116
2020-07-06 2020-07-01 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
3,053 -11.6%
26.39
US$80,563 		3,053 -11.6% 26.39 US$80,563
2020-07-06 2020-07-01 PlS Planned sale
Brown Bob D

See Remarks

Officer
2,371 -32.2%
26.85
US$63,669 		2,371 -32.2% 26.85 US$63,669
2020-07-06 2020-07-01 PlS Planned sale
Brown Bob D

See Remarks

Officer
5,814 -44.1%
26.36
US$153,259 		5,814 -44.1% 26.36 US$153,259
2020-06-23 2020-06-19 PlS Planned sale
Brown Bob D

See Remarks

Officer
9,670 -65.9%
25.00
US$241,750 		9,670 -65.9% 25.00 US$241,750
2020-06-02 2020-06-01 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
4,360 -16.6%
21.06
US$91,807 		4,360 -16.6% 21.06 US$91,807
2020-06-02 2020-06-01 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -62.1%
21.01
US$171,959 		8,185 -62.1% 21.01 US$171,959
2020-05-12 2020-05-11 PlS Planned sale
Brown Bob D

See Remarks

Officer
13,281 -72.6%
24.00
US$318,744 		13,281 -72.6% 24.00 US$318,744
2020-05-07 2020-05-05 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -62.1%
21.00
US$171,885 		8,185 -62.1% 21.00 US$171,885
2020-05-06 2020-05-04 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
4,360 -16.6%
20.20
US$88,072 		4,360 -16.6% 20.20 US$88,072
2020-04-22 2020-04-20 PlS Planned sale
GREEN JOHN B

Chief Financial Officer

Officer
25,624 -56.9%
22.95
US$588,071 		25,624 -56.9% 22.95 US$588,071
2020-04-21 2020-04-20 PlS Planned sale
Brown Bob D

See Remarks

Officer
13,281 -72.6%
23.00
US$305,463 		13,281 -72.6% 23.00 US$305,463
2020-04-21 2020-04-17 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -62.1%
21.18
US$173,358 		8,185 -62.1% 21.18 US$173,358
2020-04-14 2020-04-13 PlS Planned sale
Weissman James B

Chief Operating Officer & EVP

Officer
4,360 -16.6%
20.20
US$88,072 		4,360 -16.6% 20.20 US$88,072
2020-04-09 2020-04-07 PlS Planned sale
GREEN JOHN B

Chief Financial Officer

Officer
20,469 -51.3%
19.95
US$408,357 		20,469 -51.3% 19.95 US$408,357
2020-03-03 2020-03-02 PlS Planned sale
Weissman James B

EVP & Chief Operating Officer

Officer
4,360 -16.6%
20.61
US$89,854 		4,360 -16.6% 20.61 US$89,854
2020-03-03 2020-03-02 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -62.1%
21.00
US$171,885 		8,185 -62.1% 21.00 US$171,885
2020-02-11 2020-02-10 PlS Planned sale
Brown Bob D

See Remarks

Officer
8,185 -62.1%
21.00
US$171,885 		8,185 -62.1% 21.00 US$171,885
2020-02-04 2020-02-03 PlS Planned sale
Weissman James B

EVP & Chief Operating Officer
4,360 -16.6%
20.20
US$88,072 		4,360 -16.6% 20.20 US$88,072
2020-01-21 2020-01-17 PlS Planned sale
GREEN JOHN B

Chief Financial Officer
20,469 -51.3%
21.26
US$435,228 		20,469 -51.3% 21.26 US$435,228
2020-01-21 2020-01-17 PlS Planned sale
GREEN JOHN B

Chief Financial Officer
27,500 -40.8%
21.27
US$584,936 		27,500 -40.8% 21.27 US$584,936
2020-01-03 2020-01-02 PlS Planned sale
Weissman James B

EVP & Chief Operating Officer
4,360 -16.6%
21.88
US$95,376 		4,360 -16.6% 21.88 US$95,376
2019-12-31 2019-12-31 PlS Planned sale Brown Bob D

See Remarks

Officer
11,941 -70.5%
22.00
US$262,702 		11,941 -70.5% 22.00 US$262,702
2019-12-31 2019-12-30 PlS Planned sale Brown Bob D

See Remarks

Officer
1,340 -100.0%
22.01
US$29,487 		1,340 -100.0% 22.01 US$29,487
2019-12-31 2019-12-30 PlS Planned sale Brown Bob D

See Remarks

Officer
21,466 -94.1%
21.84
US$468,914 		21,466 -94.1% 21.84 US$468,914
2019-12-27 2019-12-26 PlS Planned sale ROSSKAMP RALF

Chief Medical Officer

Officer
20,000 -84.9%
22.69
US$453,764 		20,000 -84.9% 22.69 US$453,764
Explore more

More insider trading research around Dicerna Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America